GE HealthCare Technologies (GEHC) Income from Continuing Operations (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Income from Continuing Operations of 411000000.0 for Q1 2026, down 31.73% on a QoQ basis from 602000000.0 in Q4 2025, and down 30.1% year-over-year from 588000000.0 in Q1 2025.
GE HealthCare Technologies (GEHC) Income from Continuing Operations (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 411000000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 30.1% year-over-year to 411000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1977000000.0 (down 12.17% YoY) and the FY2025 annual result came in at 2154000000.0, up 5.07% from the prior year.
- Income from Continuing Operations was 411000000.0 for Q1 2026 at GE HealthCare Technologies, down from 602000000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 738000000.0 in Q4 2024 and bottomed at 383000000.0 in Q1 2023.
- A 5-year average of 481294117.65 and a median of 464000000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations surged 77.4% — and 2026, when it slumped 30.1%.
- GE HealthCare Technologies' Income from Continuing Operations stood at 567000000.0 in 2022, then decreased by 26.63% to 416000000.0 in 2023, then soared by 77.4% to 738000000.0 in 2024, then fell by 18.43% to 602000000.0 in 2025, then plunged by 31.73% to 411000000.0 in 2026.
- Business Quant data shows GEHC's Income from Continuing Operations at 411000000.0 in Q1 2026, 602000000.0 in Q4 2025, and 464000000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 220.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411.00 Mn |
| Dec 31, 2025 | 602.00 Mn |
| Sep 30, 2025 | 464.00 Mn |
| Jun 30, 2025 | 500.00 Mn |
| Mar 31, 2025 | 588.00 Mn |
| Dec 31, 2024 | 738.00 Mn |
| Sep 30, 2024 | 490.00 Mn |
| Jun 30, 2024 | 435.00 Mn |
| Mar 31, 2024 | 388.00 Mn |
| Dec 31, 2023 | 416.00 Mn |
| Sep 30, 2023 | 386.00 Mn |
| Jun 30, 2023 | 433.00 Mn |
| Mar 31, 2023 | 383.00 Mn |
| Dec 31, 2022 | 567.00 Mn |
| Sep 30, 2022 | 493.00 Mn |
| Jun 30, 2022 | 486.00 Mn |
| Mar 31, 2022 | 402.00 Mn |